Skip to main content
Log in

Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

  • Review
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Flavonoids are an important class of natural polyphenolic compounds reported to exert beneficial effects in cardiovascular and metabolic diseases, cancer, autoimmune and neurological disorders. Flavonoids possess potential antioxidant, anti-inflammatory, antiapoptotic and immuno-modulation properties. Intriguingly, the importance of flavonoids in different neurological disorders is gaining more attention due to the safety, better pharmacokinetic profile and blood–brain barrier penetration, cost-effectiveness and readiness for clinical uses/trials. Many in vitro and in vivo research studies have established the neuroprotective mechanism of flavonoids in the central nervous system (CNS) diseases. The present review summarizes the benefits of various classes of flavonoids (flavones, flavonols, flavanones, anthocyanidins, isoflavones, flavanols), chemical nature, classification, their occurrence and distribution, pharmacokinetics and bioavailability. The manuscript also presents available evidences relating to the role of flavonoids in regulating key signaling pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, mitogen-activated protein kinase (MAPK) pathway, Janus kinase and signal transducer and activator of transcription proteins (JAK/STAT) pathway, Toll-like receptors (TLR) pathway, nuclear factor erythroid 2-related factor 2 (Nrf2) pathway and cAMP response element-binding protein (CREB) pathway involved in neuroinflammation associated with major neurological disorders. Literature search was conducted using electronic databases like Google Scholar, Scopus, PubMed central, Springer search and Web of science. Chemical structures used in the present analysis were drawn using Chemdraw Professional 15.0 software. This collective information provides comprehensive knowledge on disease pathways and therapeutic benefits of flavonoids in neurological disorders, druggability and future scope for research.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Abbreviations

CNS:

Central nervous system

NF-κB:

Nuclear factor kappa-light-chain-enhancer of activated B cells

MAPK:

Mitogen-activated protein kinase

JAK/STAT:

Janus kinase and signal transducer and activator of transcription proteins

TLR:

Toll-like receptors

Nrf2:

Nuclear factor erythroid 2-related factor 2

CREB:

CAMP response element-binding protein

NI:

Neuroinflammation

DC:

Dendritic cells

NKT:

Natural killer T

NK:

Natural killer

CD4:

Cluster of differentiation 4

CD8:

Cluster of differentiation 8

B cells:

B lymphocytes

PD:

Parkinson’s disease

MS:

Multiple sclerosis

AD:

Alzheimer’s disease

HD:

Huntington’s disease

iNOS:

Inducible nitric oxide synthase

NO:

Nitric oxide

NADPH:

Nicotinamide adenine dinucleotide phosphate

ECG:

Epicatechin-3-gallate

EGC:

Epigallocatechin

EC:

Epicatechin

GCG:

Gallocatechin-3-gallate

GC:

Gallocatechin

EGCG:

Epigallocatechin-3-gallate

C:

Catechin

ALS:

Amyotrophic lateral sclerosis

EAE:

Experimental autoimmune encephalomyelitis

TNF-α:

Tumor necrosis factor-alpha

TLR4:

Toll-like receptor 4

mRNA:

Messenger RNA (ribonucleic acid)

BDNF:

Brain-derived neurotrophic factor

HO-1:

Heme oxygenase 1

PGE2:

Prostaglandin E2

ERK:

Extracellular-signal-regulated kinase

c-JNK:

c-Jun N-terminal Kinase

GCLC:

Glutamate-cysteine ligase catalytic subunit

PI3K/AKT:

Phosphatidylinositol 3-kinase/protein kinase B

TYK2:

Tyrosine kinase 2

Th1:

T helper type 1

Th17:

T helper type 17

IL-17:

Interleukin-17

STAT3:

Signal transducer and activator of transcription protein 3

IFN-γ:

Interferon γ

IL-12:

Interleukin-12

STAT4:

Signal transducer and activator of transcription protein 4

CD40:

Cluster of differentiation 40

STAT1:

Signal transducer and activator of transcription protein 1

NDs:

Neurodegenerative diseases

ND:

Neurodegenerative disease

Aβ-RAGE:

Amyloid beta-receptor for advanced glycation end products

MAPKAP kinase2(MK2)HSP27:

MAPK-activated protein kinase-2-heat-shock protein 27

IL-1β:

Interleukin 1beta

ROS:

Reactive oxygen species

IL-6:

Interleukin 6

JAK2:

Janus kinase 2

SAPK/c:

Stress-activated protein kinase/c

TRIF:

Toll/Interleukin-1 receptor-like (TIR) domain-containing adaptor inducing interferon-β

LPO:

Lipoperoxidation

IRF3:

Interferon regulatory factor 3

MyD88:

Myeloid differentiation primary response 88

TLR4/NOX4:

Toll-like receptor 4/NADPH oxidase 4

TLR2:

Toll-like receptor 2

TRAF6:

Tumor necrosis factor receptor (TNFR)-associated factor 6

PGE2:

Prostaglandin E2

COX-2:

Cyclooxygenase 2

ARE:

Antioxidant response element

p-ERK:

Phosphorylated extracellular signal regulated kinase

PI3K/AKT:

Phosphatidylinositol 3-kinase/protein kinase B

GSK3β:

Glycogen synthase kinase -3β

Keap-1:

Kelch-like ECH-associated protein 1

IFN-β:

Interferon β

HMF:

3,5,6,7,8,3’,4’-Heptamethoxyflavone

TrkA:

Tropomyosin receptor kinase A

NGF:

Nerve growth factor

NQO1:

NAD(P)H:quinone oxidoreductase 1

CAT:

Catalase

SOD1:

Superoxide dismutase 1

CDK5:

Cyclin-dependent-like kinase 5

PAMPs:

Pathogen-associated molecular patterns

References

Download references

Acknowledgements

Hamsalakshmi gratefully acknowledges the Department of Science and Technology, Govt. of India, New Delhi for granting the INSPIRE fellowship (Application No: DST/INSPIRE/03/2016/000956) to carry out the research. The authors are grateful to Dr. Gopinath Meenakshisundaram, Department of Molecular Nutrition, CSIR, CFTRI, Mysuru, Karnataka, India for his diligent proofreading of this paper and suggestions.

Funding

This work did not receive any specific grant or funds.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Suresh Joghee or Saravana Babu Chidambaram.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamsalakshmi, Alex, A.M., Arehally Marappa, M. et al. Therapeutic benefits of flavonoids against neuroinflammation: a systematic review. Inflammopharmacol 30, 111–136 (2022). https://doi.org/10.1007/s10787-021-00895-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-021-00895-8

Keywords

Navigation